Keyphrases
Cancer Therapy
100%
MicroRNA
100%
Targeted Delivery
100%
Microvesicles
100%
Short Hairpin RNA (shRNA)
28%
Synthetic Oligonucleotides
28%
Target Molecule
28%
Drug Delivery System
28%
Cancer Cells
28%
MiRNA Sequencing
14%
Delivery System
14%
TAT Peptide
14%
Biological Activity
14%
Pharmacodynamic Evaluation
14%
Peptide Binding
14%
Therapeutic nucleic Acids
14%
Biochemical Approaches
14%
Nucleic Acid Drug
14%
C-terminus
14%
TAR RNA
14%
Pharmacokinetic Evaluation
14%
Endocytic
14%
Pre-miR
14%
Targeting Ability
14%
Activity Capacity
14%
MiR-199a-3p
14%
HIV-1 Tat
14%
Oligonucleotides
14%
Tumor Suppression
14%
Targeted Therapeutics
14%
Biodistribution
14%
Loop Region
14%
Orthotopic Model
14%
Tumor
14%
Pre-miRNA
14%
Therapeutic Oligonucleotides
14%
Cargo
14%
Hepatocellular Carcinoma
14%
Targeting Peptide
14%
Membrane Vesicles
14%
Processing Activities
14%
Protein-coding Genes
14%
Hepatocellular Carcinoma Cells
14%
Route of Administration
14%
Clinical Development
14%
Therapeutic Action
14%
New Therapeutic Modalities
14%
In Silico Methods
14%
Nucleic Acids
14%
Therapeutic Targeting
14%
Biochemistry, Genetics and Molecular Biology
Oligonucleotide
100%
Membrane Microparticle
100%
MicroRNA
100%
Microvesicles
75%
Nucleic Acid
75%
Targeting Protein
50%
Cancer Cell
50%
Membrane Vesicle
25%
Tat (HIV)
25%
Pharmacokinetics
25%
C-Terminus
25%
Small Hairpin RNA
25%
Biological Activity
25%
Pharmacodynamics
25%
Biodistribution
25%
Intron
25%
RNA
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
microRNA
100%
Oligonucleotide
80%
Nucleic Acid
60%
Drug Delivery System
40%
Neoplasm
40%
Liver Cell Carcinoma
40%
Biodistribution
20%
Route of Administration
20%
Disease
20%
Dose Toxicity
20%
Pharmacodynamics
20%
Drug
20%
Short Hairpin RNA
20%
HIV
20%
Biological Activity
20%
Pharmacokinetics
20%